Loading…

Carcinoid heart disease: Current understanding and future directions

Carcinoid tumors are rare and aggressive malignancies. A multitude of vasoactive agents are central to the systemic effects of these tumors. The additional burden of cardiac dysfunction heralds a steep decline in quality of life and survival. Unfortunately, by the time carcinoid syndrome surfaces cl...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2014-06, Vol.167 (6), p.789-795
Main Authors: Patel, Chirdeep, MD, Mathur, Moses, MD, MSc, Escarcega, Ricardo O., MD, Bove, Alfred A., MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Carcinoid tumors are rare and aggressive malignancies. A multitude of vasoactive agents are central to the systemic effects of these tumors. The additional burden of cardiac dysfunction heralds a steep decline in quality of life and survival. Unfortunately, by the time carcinoid syndrome surfaces clinically, the likelihood of cardiac involvement is 50%. Although medical therapies such as somatostatin analogues may provide some symptom relief, they offer no mortality benefit. On the other hand, referral to surgery following early detection has shown increased survival. The prompt recognition of this disease is therefore of the utmost importance.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2014.03.018